KOPN · Kopin Corp - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $10.55M | - | $11.96M | $8.45M | $10.54M | - | $13.32M | $12.34M | $10.03M | - |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - |
| R&D | $1.11M | - | $2.50M | $1.95M | $2.12M | - | $2.60M | $1.84M | $2.10M | - |
| SG&A | $6.02M | - | $1.63M | $4.90M | $4.70M | - | $5.21M | $7.27M | $7.23M | - |
| Total Operating Expenses | $16.54M | - | $7.43M | $13.92M | $14.45M | - | $16.12M | $17.79M | $42.67M | - |
| D&A | $247.0K | - | - | - | $219.5K | - | - | - | $195.4K | - |
| Operating Income | ($5.99M) | - | $4.53M | ($5.46M) | ($3.91M) | - | ($2.80M) | ($5.46M) | ($32.64M) | - |
| Interest Expense | - | - | - | - | - | - | - | - | - | - |
| Income Tax | $57.0K | - | $52.0K | $52.0K | $52.0K | - | $125.0K | - | - | - |
| Net Income | ($3.75M) | - | $4.08M | ($5.17M) | ($3.11M) | - | ($3.46M) | ($5.92M) | ($32.55M) | - |
| EPS - Basic | ($0.02) | - | $0.02 | ($0.03) | ($0.02) | - | ($0.03) | ($0.05) | ($0.27) | - |
| EPS - Diluted | ($0.02) | - | $0.02 | ($0.03) | ($0.02) | - | ($0.03) | ($0.05) | ($0.03) | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $34.10M | $36.40M | $26.51M | $24.37M | $15.33M | $14.16M | $14.53M | $10.04M | $14.12M | $5.71M |
| Accounts Receivable | $3.44M | $10.73M | $6.36M | $9.48M | $11.85M | $11.85M | $9.23M | $7.41M | $6.80M | $9.71M |
| Inventory | $4.98M | $5.51M | $6.29M | $6.69M | $6.06M | $6.13M | $6.56M | $5.65M | $6.12M | $7.60M |
| Accounts Payable | $5.71M | $5.32M | $6.13M | $4.13M | $3.43M | $5.94M | $4.39M | $5.71M | $8.99M | $7.08M |
| Current Assets | $82.42M | $91.81M | $53.18M | $52.64M | $57.12M | $62.84M | $63.00M | $40.32M | $41.99M | $39.83M |
| Total Assets | $102.44M | $108.39M | $61.22M | $61.18M | $65.04M | $70.77M | $70.58M | $49.05M | $51.27M | $49.31M |
| Current Liabilities | $31.53M | $33.99M | $36.27M | $41.43M | $40.94M | $43.94M | $43.95M | $45.35M | $42.51M | $15.88M |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $34.02M | $36.72M | $39.89M | $45.14M | $44.36M | $47.48M | $47.85M | $49.26M | $46.33M | $19.80M |
| Stockholders' Equity | $60.83M | $64.12M | $21.32M | $16.04M | $20.68M | $23.28M | $22.73M | ($216.3K) | $4.94M | $29.51M |
| Retained Earnings | ($403.17M) | ($399.42M) | ($406.23M) | ($410.31M) | ($405.15M) | ($402.03M) | ($400.09M) | ($396.63M) | ($390.70M) | ($358.16M) |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ($810.7K) | - | - | - | ($3.41M) | - | - | - | ($3.11M) | - |
| Investing Cash Flow | ($1.30M) | - | - | - | $4.59M | - | - | - | $4.52M | - |
| Financing Cash Flow | ($29.2K) | - | - | - | - | - | - | - | $7.24M | - |
| CapEx | $1.30M | - | - | - | $500.5K | - | - | - | $245.4K | - |
| Free Cash Flow | ($2.11M) | - | - | - | ($3.91M) | - | - | - | ($3.35M) | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | -56.7% | - | 37.9% | -64.6% | -37.1% | - | -21.0% | -44.2% | -325.4% | - |
| EBITDA margin | -54.4% | - | - | - | -35.0% | - | - | - | -323.4% | - |
| Net margin | -35.6% | - | 34.1% | -61.1% | -29.5% | - | -26.0% | -48.0% | -324.4% | - |
| Free cash flow margin | -20.0% | - | - | - | -37.1% | - | - | - | -33.4% | - |
| FCF / Net income | 0.56 | - | - | - | 1.26 | - | - | - | 0.10 | - |
| R&D / Revenue | 10.5% | - | 20.9% | 23.0% | 20.1% | - | 19.5% | 14.9% | 20.9% | - |
| SG&A / Revenue | 57.0% | - | 13.6% | 57.9% | 44.6% | - | 39.1% | 58.9% | 72.1% | - |
| Effective tax rate | - | - | 1.3% | - | - | - | - | - | - | - |
| Return on assets | -3.7% | - | 6.7% | -8.4% | -4.8% | - | -4.9% | -12.1% | -63.5% | - |
| Return on equity | -6.2% | - | 19.1% | -32.2% | -15.1% | - | -15.2% | 2737.3% | -658.9% | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 2.61 | 2.70 | 1.47 | 1.27 | 1.40 | 1.43 | 1.43 | 0.89 | 0.99 | 2.51 |
| Quick ratio | 2.46 | 2.54 | 1.29 | 1.11 | 1.25 | 1.29 | 1.28 | 0.76 | 0.84 | 2.03 |
| Cash ratio | 1.08 | 1.07 | 0.73 | 0.59 | 0.37 | 0.32 | 0.33 | 0.22 | 0.33 | 0.36 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | - | - | - | - | - | - |
| Equity multiplier | 1.68 | 1.69 | 2.87 | 3.81 | 3.14 | 3.04 | 3.11 | -226.72 | 10.38 | 1.67 |
| Liabilities / Assets | 0.33 | 0.34 | 0.65 | 0.74 | 0.68 | 0.67 | 0.68 | 1.00 | 0.90 | 0.40 |
| Efficiency | ||||||||||
| Asset turnover | 0.10 | - | 0.20 | 0.14 | 0.16 | - | 0.19 | 0.25 | 0.20 | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | 119d | - | 194d | 409d | 410d | - | 253d | 219d | 247d | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | 114.0x | - | - | - | - | - | - | - |
| P / B | 5.6x | - | 18.1x | 16.1x | 7.6x | - | 3.9x | - | 38.3x | - |
| P / S | 32.2x | - | 32.3x | 30.5x | 15.0x | - | 6.6x | 8.3x | 18.8x | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 0.1% | - | -10.2% | -31.5% | 5.0% | - | 25.7% | 17.9% | -6.7% | - |
| Revenue CAGR (3y) | -0.6% | - | 0.7% | -10.8% | -3.1% | - | 7.0% | 7.6% | -4.9% | - |
| Revenue CAGR (5y) | -2.0% | - | 4.7% | -0.8% | 6.0% | - | 16.8% | 6.3% | 12.6% | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | -53.2% | - | - | -0.1% | 88.0% | - | -2.7% | -12.8% | -1054.9% | - |
| Net income growth (YoY) | -20.5% | - | - | 12.8% | 90.4% | - | -41.2% | 27.6% | -1138.3% | - |
| EPS growth (YoY) | 0.0% | - | - | 40.0% | 33.3% | - | 57.1% | 28.6% | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | 46.0% | - | - | - | -16.8% | - | - | - | 23.7% | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | 194.1% | 175.4% | -6.2% | - | 318.6% | -21.1% | -33.9% | - | -88.5% | 22.1% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-27.
Product / service
$151.04M totalASCSix Zero Six Revenues$38.07M · 25.2%
Net Product Revenue$33.07M · 21.9%
Net Product Revenues$33.07M · 21.9%
Defense$29.36M · 19.4%
Research And Development$4.59M · 3.0%
Research And Development Revenues$4.59M · 3.0%
Industrial$3.02M · 2.0%
Non ASCSix Zero Six Revenues$1.26M · 0.8%
Grant Income$858.1K · 0.6%
Grant$858.0K · 0.6%
Medical$594.0K · 0.4%
License And Royalties$410.0K · 0.3%
License And Other Revenues$409.9K · 0.3%
Collaboration$399.0K · 0.3%
Collaboration Arrangement Income$398.9K · 0.3%
Other Product$78.0K · 0.1%
Consumer$9.0K · 0.0%
Geographic
$76.53M totalAmericas$37.21M · 48.6%
US$37.15M · 48.5%
Asia Pacific$1.15M · 1.5%
Europe$961.0K · 1.3%
Other Americas$62.0K · 0.1%
Peer comparison
Same SIC group: Semiconductors & Related Devices
Comparing KOPIN CORP against the 5 most active filers in the same SIC group.